WELL Health Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

WELL Health Technologies şirketinin toplam hissedar öz sermayesi CA$918.0M ve toplam borcu CA$320.0M olup, bu da borç-öz sermaye oranını 34.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CA$1.6B ve CA$675.1M dir. WELL Health Technologies 'in FAVÖK'ü CA$57.8M faiz karşılama oranı 1.6 dur. Şirketin CA$66.2M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

34.9%

Borç/özkaynak oranı

CA$320.02m

Borç

Faiz karşılama oranı	1.6x
Nakit	CA$66.15m
Eşitlik	CA$918.03m
Toplam yükümlülükler	CA$675.10m
Toplam varlıklar	CA$1.59b

Son finansal sağlık güncellemeleri

Recent updates

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Nov 11

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Sep 09

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Jul 05

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

May 21

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Mar 21

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Feb 29

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

Jan 18

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Oct 30

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

Jul 17

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Apr 18

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?

Jan 13

Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?

Nov 11

Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?

Aug 09

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price

May 31

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: WELL 'nin kısa vadeli varlıkları ( CA$314.9M ) kısa vadeli yükümlülüklerini ( CA$277.2M ) aşıyor.

Uzun Vadeli Yükümlülükler: WELL 'un kısa vadeli varlıkları ( CA$314.9M ) uzun vadeli yükümlülüklerini ( CA$397.9M ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: WELL 'nin net borç/öz sermaye oranı ( 27.7% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: WELL 'nin borç/öz sermaye oranı son 5 yılda 54.1% seviyesinden 34.9% seviyesine düştü.

Borç Kapsamı: WELL 'nin borcu işletme nakit akışı ( 39.6% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: WELL 'in borcuna ilişkin faiz ödemeleri EBIT ( 1.6 x kapsam) tarafından iyi karşılanmıyor.

WELL Health Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Recent updates

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Chief Operating Officer exercised options to buy CA$1.6m worth of stock.

New major risk - Revenue and earnings growth

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Independent Director exercised options and sold CA$144k worth of stock

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

Consensus EPS estimates upgraded to CA$0.08 loss

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Independent Director recently sold CA$160k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.

Consensus estimates of losses per share improve by 22%

Second quarter 2023 earnings: EPS exceeds analyst expectations

WELL Health Technologies Corp. to Report Q2, 2023 Results on Aug 10, 2023

Founder exercised options and sold CA$527k worth of stock

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc.

Consensus EPS estimates fall by 11%, revenue upgraded

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

Consensus EPS estimates fall by 11%, revenue upgraded

Well Health Technologies Corp. Provides Revenue Guidance for the Year 2023

Chief Financial Officer exercised options to buy CA$1.5m worth of stock.

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

Founder exercised options and sold CA$204k worth of stock

Consensus EPS estimates fall by 60%

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

Consensus EPS estimates fall by 108%, revenue upgraded

WELL Health Technologies Corp. Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. Announces the Launch of Its Ground-Breaking Product, WELL AI Voice

WELL Health Technologies Corp. to Report Q1, 2023 Results on May 12, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Full year 2022 earnings released: EPS: CA$0.006 (vs CA$0.23 loss in FY 2021)

Consensus EPS estimates fall by 77%

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?

Consensus estimates of losses per share improve by 24%

Forecast to breakeven in 2024

Forecast to breakeven in 2024

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

WELL Health Technologies Corp. Increases Annual Revenue Guidance for 2022

Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?

WELL Health Technologies Corp. to Report Q3, 2022 Results on Nov 10, 2022

Independent Director recently sold CA$357k worth of stock